English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Melatonin receptors as a target to treat alcohol addiction

Vengeliene, V., Noori, H., Takahashi, T., & Spanagel, R. (2017). Melatonin receptors as a target to treat alcohol addiction. European Neuropsychopharmacology, 27(Supplement 4), S570-S570.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/21.11116/0000-0000-C566-F Version Permalink: http://hdl.handle.net/21.11116/0000-0000-C567-E
Genre: Meeting Abstract

Files

show Files

Locators

show
hide
Locator:
Link (Any fulltext)
Description:
-

Creators

show
hide
 Creators:
Vengeliene, V, Author
Noori, HR1, 2, Author              
Takahashi, TT, Author
Spanagel, R, Author
Affiliations:
1Research Group Neuronal Convergence, Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_2528694              
2Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497794              

Content

show
hide
Free keywords: -
 Abstract: Reduced levels of melatonin and a delay of its nocturnal peak concentration have been found in alcohol dependent patients and alcohol drinking rats [1,2]. In this study, we investigated whether the melatonergic system can be used to treat alcohol addiction. Male rats were subjected to long-term voluntary alcohol consumption with repeated abstinence phases. Circadian drinking rhythmicity and patterns were registered with high temporal resolution by a drinkometer system and analysed by Fourier analysis.We examined potential anti-relapse effect of the antidepressant drug agomelatine. Given that agomelatine is a potent MT1 and MT2 receptor agonist we also tested the effect of melatonin itself. Agomelatine and melatonin administered just before the dark phase led to very similar changes on all measures of the post-abstinence drinking behaviour, suggesting that effects of agomelatine on relapse-like behaviour are mostly driven by its melatonergic activity. Both drugs caused a clear phase advance in the diurnal drinking pattern compared to vehicle-treated rats and a reduced frequency of approaches to alcohol bottles. Melatonin given at the onset of the light phase had no effect on the circadian phase and very small effect on alcohol consumption [3]. We conclude that targeting the melatonergic system in alcohol dependent individuals can induce a circadian phase advance, which may restore normal sleep architecture and reduce relapse behaviour. This effect of melatonin may not be restricted to alcohol-related behaviours.We also showed that administration of melatonin lowered cue-induced cocaineseeking behaviour and motivation to self-administer cocaine [4].

Details

show
hide
Language(s):
 Dates: 2017-09
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: DOI: 10.1016/S0924-977X(17)30965-3
BibTex Citekey: VengelieneNTS2017
 Degree: -

Event

show
hide
Title: 30th European College Neuropsychopharmacology Congress (ECNP 2017)
Place of Event: Paris, France
Start-/End Date: -

Legal Case

show

Project information

show

Source 1

show
hide
Title: European Neuropsychopharmacology
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 27 (Supplement 4) Sequence Number: - Start / End Page: S570 - S570 Identifier: -